Hongbo Lu's most recent trade in Terns Pharmaceuticals Inc was a trade of 45,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Zenas Biopharma Inc. | Hongbo Lu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 10,657 | 10,657 | - | - | Stock Option (Right to Buy) | |
| Arrowhead Pharmaceuticals ... | Hongbo Lu | Director | Grant, award, or other acquisition of securities at price $ 22.99 per share. | 18 Dec 2024 | 16,733 | 47,163 (0%) | 0% | 23.0 | 384,692 | Common Stock |
| Arrowhead Pharmaceuticals ... | Hongbo Lu | Director | 30 Sep 2024 | 5,650 | 30,430 (0%) | 0% | 0 | Common Stock | ||
| Arrowhead Pharmaceuticals ... | Hongbo Lu | Director | 30 Sep 2024 | 850 | 34,930 (0%) | 0% | 27.5 | 23,375 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Hongbo Lu | Director | 30 Sep 2024 | 500 | 36,080 (0%) | 0% | 22 | 11,000 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Hongbo Lu | Director | 30 Sep 2024 | 500 | 35,580 (0%) | 0% | 25 | 12,500 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Hongbo Lu | Director | 30 Sep 2024 | 400 | 34,080 (0%) | 0% | 28 | 11,200 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Hongbo Lu | Director | 30 Sep 2024 | 150 | 35,080 (0%) | 0% | 27.3 | 4,101 | Common Stock | |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Purchase of securities on an exchange or from another person at price $ 10.50 per share. | 12 Sep 2024 | 285,714 | 476,190 | - | 10.5 | 2,999,997 | Common Stock |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Purchase of securities on an exchange or from another person at price $ 10.50 per share. | 12 Sep 2024 | 190,476 | 190,476 | - | 10.5 | 1,999,998 | Common Stock |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 4,676 | 4,676 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Arrowhead Pharmaceuticals ... | Hongbo Lu | Director | Purchase of securities on an exchange or from another person at price $ 27.49 per share. | 18 Mar 2024 | 1,000 | 31,680 (0%) | 0% | 27.5 | 27,490 | Common Stock |
| Arrowhead Pharmaceuticals ... | Hongbo Lu | Director | Purchase of securities on an exchange or from another person at price $ 27.50 per share. | 18 Mar 2024 | 1,000 | 33,680 (0%) | 0% | 27.5 | 27,500 | Common Stock |
| Arrowhead Pharmaceuticals ... | Hongbo Lu | Director | Purchase of securities on an exchange or from another person at price $ 28.00 per share. | 18 Mar 2024 | 1,000 | 32,680 (0%) | 0% | 28 | 28,000 | Common Stock |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Purchase of securities on an exchange or from another person at price $ 7.25 per share. | 23 Dec 2022 | 758,620 | 4,340,212 | - | 7.3 | 5,499,995 | Common Stock |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 07 Sep 2022 | 600,000 | 3,581,592 | - | 3.6 | 2,160,000 | Common Stock |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Purchase of securities on an exchange or from another person at price $ 2.42 per share. | 12 Aug 2022 | 1,500,000 | 2,981,592 | - | 2.4 | 3,630,000 | Common Stock |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Aug 2022 | 1,500,000 | 1,500,000 | - | - | Pre-funded Warrants (right to buy) | |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Purchase of securities on an exchange or from another person at price $ 2.98 per share. | 12 Aug 2022 | 1,123,021 | 1,480,374 | - | 3.0 | 3,346,603 | Common Stock |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 12 Aug 2022 | 1,218 | 1,481,592 | - | 3.0 | 3,642 | Common Stock |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Hongbo Lu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |